Keywords: first, treatment, ph, ii, cytofab, trial, program

First treatment in Ph II CytoFab trial program

Article | 28 January 2008

Print This

UK-based Protherics says that Anglo-Swedish drug major AstraZeneca has treated the first patient in its expanded Phase II program of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in